SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-764344
Filing Date
2016-11-09
Accepted
2016-11-09 16:11:52
Documents
56
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM10-Q d237170d10q.htm 10-Q 338366
2 CERTIFICATION d237170dex311.htm EX-31.1 8254
3 CERTIFICATION d237170dex312.htm EX-31.2 8239
4 CERTIFICATION d237170dex321.htm EX-32.1 3585
5 CERTIFICATION d237170dex322.htm EX-32.2 3580
  Complete submission text file 0001193125-16-764344.txt   2671644

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cprx-20160930.xml EX-101.INS 462127
7 XBRL TAXONOMY EXTENSION SCHEMA cprx-20160930.xsd EX-101.SCH 39487
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20160930_cal.xml EX-101.CAL 47657
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20160930_def.xml EX-101.DEF 118329
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20160930_lab.xml EX-101.LAB 300886
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20160930_pre.xml EX-101.PRE 207132
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 161984346
SIC: 2834 Pharmaceutical Preparations